Niesvizky R - Search Results

1

Phase Ib dose-escalation study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma.

Niesvizky R, Martin TG 3rd, Bensinger WI, Alsina M, Siegel DS, Kunkel LA, Wong AF, Lee S, Orlowski RZ, Wang M. Niesvizky R, et al. Clin Cancer Res. 2013 Apr 15;19(8):2248-56. doi: 10.1158/1078-0432.CCR-12-3352. Epub 2013 Feb 27. Clin Cancer Res. 2013. PMID: 23447001 Free PMC article. Clinical Trial.

2

2-Chlorodeoxyadenosine for multiple myeloma.

Niesvizky R, Siegel D, Michaeli J. Niesvizky R, et al. Blood. 1993 Feb 1;81(3):868-9. Blood. 1993. PMID: 7679003 Free article. No abstract available.

3

Hypercalcaemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myeloma.

Niesvizky R, Siegel DS, Busquets X, Nichols G, Muindi J, Warrell RP Jr, Michaeli J. Niesvizky R, et al. Br J Haematol. 1995 Jan;89(1):217-8. doi: 10.1111/j.1365-2141.1995.tb08936.x. Br J Haematol. 1995. PMID: 7833269 Clinical Trial.

4

Biology and treatment of multiple myeloma.

Niesvizky R, Siegel D, Michaeli J. Niesvizky R, et al. Blood Rev. 1993 Mar;7(1):24-33. doi: 10.1016/0268-960x(93)90021-u. Blood Rev. 1993. PMID: 8467229 Review.

5

Impact of early response to sequential high-dose chemotherapy on outcome of patients with advanced myeloma and poor prognostic features.

Niesvizky R, Siegel D, Glassman J, Straus D, Fine J, Lyons L, Michaeli J. Niesvizky R, et al. Leuk Lymphoma. 2002 Mar;43(3):607-12. doi: 10.1080/10428190210324. Leuk Lymphoma. 2002. PMID: 12002766 Clinical Trial.

6

BLT-D (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenström's macroglobulinemia.

Coleman M, Leonard J, Lyons L, Pekle K, Nahum K, Pearse R, Niesvizky R, Michaeli J. Coleman M, et al. Among authors: niesvizky r. Leuk Lymphoma. 2002 Sep;43(9):1777-82. doi: 10.1080/1042819021000006303. Leuk Lymphoma. 2002. PMID: 12685831

7

Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone.

Coleman M, Leonard J, Lyons L, Szelenyi H, Niesvizky R. Coleman M, et al. Among authors: niesvizky r. Semin Oncol. 2003 Apr;30(2):270-4. doi: 10.1053/sonc.2003.50044. Semin Oncol. 2003. PMID: 12720151 Clinical Trial.

8

Kyphoplasty enhances function and structural alignment in multiple myeloma.

Lane JM, Hong R, Koob J, Kiechle T, Niesvizky R, Pearse R, Siegel D, Poynton AR. Lane JM, et al. Among authors: niesvizky r. Clin Orthop Relat Res. 2004 Sep;(426):49-53. doi: 10.1097/01.blo.0000131642.96984.74. Clin Orthop Relat Res. 2004. PMID: 15346051

9

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma.

Jagannath S, Barlogie B, Berenson J, Siegel D, Irwin D, Richardson PG, Niesvizky R, Alexanian R, Limentani SA, Alsina M, Adams J, Kauffman M, Esseltine DL, Schenkein DP, Anderson KC. Jagannath S, et al. Among authors: niesvizky r. Br J Haematol. 2004 Oct;127(2):165-72. doi: 10.1111/j.1365-2141.2004.05188.x. Br J Haematol. 2004. PMID: 15461622 Free article. Clinical Trial.

10

Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.

Leonard JP, Coleman M, Ketas J, Ashe M, Fiore JM, Furman RR, Niesvizky R, Shore T, Chadburn A, Horne H, Kovacs J, Ding CL, Wegener WA, Horak ID, Goldenberg DM. Leonard JP, et al. Among authors: niesvizky r. J Clin Oncol. 2005 Aug 1;23(22):5044-51. doi: 10.1200/JCO.2005.13.821. Epub 2005 Jun 13. J Clin Oncol. 2005. PMID: 15955901 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters